4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-033639
EVP, Chief R&D Officer sold 3,281 shares at $53.85 ($176,682)
From the SEC's structured data for this filing
Trades in this filing
Friberg Gregory R · EVP, Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-07 | Sale : show line 1 in the form | −3,281 | $53.85 | $176,682 | 51,818 | D |
| Open-market sales · 3,281 sh · avg $53.85 · $176,682 | ||||||
Loading xslF345X06/wk-form4_1778533271.xml…